Strategic engagement offering, known as Inizio Engage, aims to simplify engagement opportunities across the product lifecycle.
Inizio, a partner for health and life sciences companies that assists with various services—including patient and engagement services across a drug’s lifecycle—is launching a new strategic combination at Inizio Engage. According to the company, it combines the expertise of Ashfield Engage and The Creative Engagement Group into a unified global strategic, commercial, and creative engagement partner.
Inizio Engage was formed in response to the rapidly evolving product and commercialization landscape in health and life sciences. Due to pricing pressures and fewer product approvals, companies are looking commercialize more efficiently and realize the promise of omnichannel engagements to reach and engage with disparate healthcare provider (HCP) and patient populations.
Essentially, the offering features analytics, technology, training, and delivery experience across health and life sciences to make sure that right message is delivered to the right person, at the right time, and in the right channel. Inizio Engage’s service offerings are grouped into five specialist areas:
XD (Experience Design)
“Reaching HCPs and patients is getting more complex and challenging, due to seismic changes across the industry. That’s why we have decided to combine these two leading organizations together,” says Greg Flynn, global president, Inizio Engage. “By working as one, united, Inizio Engage brand, we can better leverage our respective talents and methodologies to create streamlined engagement opportunities across the product lifecycle, and power more effective engagement solutions. But more importantly, we empower our employees to share their passion and expertise in a broader context to deliver change in healthcare."